Exploring the Complexities of Atopic Dermatitis: Pathophysiological Mechanisms and Therapeutic Approaches

Atopic dermatitis (AD) is a complex inflammatory skin condition influenced by genetic, immunological, and environmental factors, often coexisting with conditions like alopecia areata (AA). The document highlights the shared mechanisms between AD and AA, suggesting potential treatment overlaps. Current AD management includes nonpharmacological interventions and topical corticosteroids, with a review of 219 RCTs involving 43,123 participants supporting their efficacy. However, long-term corticosteroid use poses risks, prompting the exploration of alternatives like topical calcineurin inhibitors and PDE-4 inhibitors. Emerging treatments, such as dupilumab and JAK inhibitors, show promise but require careful consideration of risks. Future strategies may focus on personalized medicine, targeting the microbiome, and identifying biomarkers to optimize treatment and improve patient outcomes.